Direct accesses

  • Go to main menu
  • Go to main content
Menu
GenSight GenSight
Search the site
  • Contact
  • Careers
  • You are viewing the website in English en
  • fr
Search the site
  • Whowe are
    • Company
    • Leadership
    • Collaborations
  • Diseaseswe target
    • Diseases we target
    • Leber Hereditary Optic Neuropathy (LHON)
    • Retinitis Pigmentosa (RP)
    • Geographic Atrophy in Dry-AMD
  • Ourtechnologies
    • Technologies we are applying
    • Gene Therapy
    • Mitochondrial Targeting Sequence (MTS)
    • Optogenetics
    • Clinical development Summary
  • Investors
    • Company Overview
    • Financial press releases
    • Investor Newsletters
    • Events & presentations
    • Stock information & Financial agenda
    • Governance
    • Documentation
  • Media

Press Releases

Filter articles using the following links
  • Financial press releases
  • Events & presentations
17 Apr 2021 - 22 Apr 2021

2021 AAN Annual Meeting, virtual

06 Apr 2021 - 09 Apr 2021

Cell & Gene Meeting on the Mediterranean, virtual

25 Mar 2021

Ophthalmology Future Forums – Asian Retina Virtual Forum

15 February 2021

GenSight Biologics Announces Publication of Results from LUMEVOQ® Phase I/IIa Clinical Trial REVEAL in BioDrugs

22 Feb 2021 - 25 Feb 2021

4th Annual Gene Therapy for Rare Disorders – virtual

18 Feb 2021

OIS Gene Therapy Innovation Showcase – virtual

06 Feb 2021 - 07 Feb 2021

44th Annual Macula Society Meeting – Virtual

04 February 2021

GenSight Biologics Announces the Publication in Communications Biology of the Proof-of-Concept for GS030-Drug Product in Non Human Primates

19 January 2021

GenSight Biologics Reports Cash Position as of December 31, 2020 and Provides Operational Update

18 January 2021

GenSight Biologics Announces its 2021 Financial Calendar

  • View previous 9 articles
  • 1
  • …
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • …
  • 42
  • View next 9 articles
© 2025 Gensight Biologics
  • Terms of use
  • Sitemap
  • Contact
  • Credits
  • Cookies management
Go back to the page of the page